Home » Newsletters » BioWorld Science

BioWorld Science

June 12, 2017

View Archived Issues

Lexicon Pharmaceuticals reports topline results from Tandem3 study of sotagliflozin

Promising in vitro data presented for GSK-830 at ICAAC

Survival increased with 131I-burtomab in central nervous system metastases of neuroblastoma

Medivir gives update on phase IIa extension study of MIV-711

RQx Pharmaceuticals and Genentech divulge bacterial spsB inhibitors

XBiotech discontinues phase III XCITE study of Xilonix

MRC Technology identifies MAP kinase-interacting serine/threonine-protein kinase 1 inhibitors

Pfizer presents immunogenic compositions for use in pneumococcal vaccines

Probiodrug reports phase IIa results on PQ-912 in early Alzheimer's disease

Phase III study of lurasidone in bipolar I depression meets primary endpoint

Metal-protein aggregate radioligand [18F]FL2-b shows brain uptake in nonhuman primates

University of Georgia and ArunA Biomedical patent neural cell extracellular vesicles

PeptiDream licenses Peptide Discovery Platform System technology to Shionogi

Norgine announces European launches of Lymphoseek

Lyvgen Biopharma Holdings presents anti-PD-1 antibodies

NIH funds collaborative New York Center for AIDS Research

Helsinn returns elsiglutide to Zealand Pharma

Basilea signs clinical study agreement with ABTC to explore use of BAL-101553 in glioblastoma

China FDA accepts fruquintinib NDA for advanced colorectal cancer

Eloxx Pharmaceuticals holds series C financing round

68Ga-NOTA-Aca-BBN(7-14) PET imaging shows promise in pediatric OPG

Takeda conducts phase I/II study of Sabin-based inactivated poliomyelitis vaccine

Boehringer Ingelheim initiates phase IIa study of BI-1467335 in NASH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...